Literature DB >> 31795779

Treatment options for tic disorders.

Renata Rizzo1, Mariangela Gulisano1.   

Abstract

Introduction: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder, characterized by the presence of multiple motor and, at least one, phonic tics, for more than one year, beginning before 18 years of age; its treatment is often a challenge for the clinicianAreas covered: GTS treatment requires a multidisciplinary management to treat each patient's symptom. Although individuals with GTS often have comorbid psychiatric disorders, the focus of this review will only be on the management of tics.Expert opinion: The authors summarized the steps that clinicians should follow treating GTS patient; the impact of the tics on a patients' life should be the first step; different patients could present different levels of tolerance to the symptoms. Second, comorbidities should be considered before starting a treatment for tic. Finally, clinicians must focus the attention of the patient and family, on the length of the treatment and the duration of time after which the effects of the drug will occur. Before the treatment, the potential side effects must be mentioned to the parents, and the choice of treatment must be made in the light of the patient's tolerance to these.

Entities:  

Keywords:  Alpha-2 agonists; Tourette syndrome; antipsychotics; tics; vesicular monoamine transporter-2 inhibitors

Mesh:

Year:  2019        PMID: 31795779     DOI: 10.1080/14737175.2020.1698950

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  3 in total

1.  A Randomized Controlled Trial Comparing Videoconference vs. Face-to-Face Delivery of Behavior Therapy for Youths With Tourette Syndrome in the Time of COVID-19.

Authors:  Adriana Prato; Nicoletta Maugeri; Flavia Chiarotti; Lucia Morcaldi; Carmelo M Vicario; Rita Barone; Renata Rizzo
Journal:  Front Psychiatry       Date:  2022-05-24       Impact factor: 5.435

2.  Use of Nutritional Supplements Based on L-Theanine and Vitamin B6 in Children with Tourette Syndrome, with Anxiety Disorders: A Pilot Study.

Authors:  Renata Rizzo; Adriana Prato; Miriam Scerbo; Federica Saia; Rita Barone; Paolo Curatolo
Journal:  Nutrients       Date:  2022-02-18       Impact factor: 5.717

Review 3.  European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.

Authors:  Veit Roessner; Heike Eichele; Jeremy S Stern; Liselotte Skov; Renata Rizzo; Nanette Mol Debes; Péter Nagy; Andrea E Cavanna; Cristiano Termine; Christos Ganos; Alexander Münchau; Natalia Szejko; Danielle Cath; Kirsten R Müller-Vahl; Cara Verdellen; Andreas Hartmann; Aribert Rothenberger; Pieter J Hoekstra; Kerstin J Plessen
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-11-10       Impact factor: 4.785

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.